The research efforts of Cynthia Blanco, MD, Medical Director of the Neonatal Nutrition & Bone Institute at University Health System and Professor of Neonatology at UT Health San Antonio, recently helped the medication Omegaven gain FDA approval. The medication, developed by German healthcare company Fresenius Kabi, helps save the lives of infants with parenteral nutrition-associated liver disease.